Business Description
2seventy bio Inc
NAICS : 325412
SIC : 2834
ISIN : US9013841070
Share Class Description:
MEX:TSVT: Ordinary SharesDescription
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment focusing on researching, developing and commercializing potentially transformative treatments for cancer.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -109.57 | |||||
OCF Margin % | -109.38 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-Forward-Revenue | 1.47 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
2seventy bio Inc Executives
DetailsGF Value™
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 951.539 | ||
| EPS (TTM) (MXN) | -2.83 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -72.66 | ||
| 3-Year Sortino Ratio | -3.46 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (MXN) | - | ||
| 20-Day SMA (MXN) | 170 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (MXN) | 170 - 170 | ||
| Shares Outstanding (Mil) | 53.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
2seventy bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
2seventy bio Inc Stock Events
| Event | Date | Price (MXN) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-02-02 08:00 | In 162 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-02 | In 161 days | ||
| Third quarter earnings conference call for 2026 | 2026-10-30 08:00 | In 67 days | ||
| Third quarter earnings results for 2026 | 2026-10-30 | In 66 days | ||
| First quarter earnings results for 2026 | 2026-08-31 | In 6 days | ||
| General meeting for 2025 | 2026-08-24 | 170.00 (+0.00%) | ||
| Second quarter earnings conference call for 2026 | 2026-08-21 08:00 | 170.00 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-08-21 | 170.00 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-07 | 170.00 (+0.00%) | ||
| Annual report for 2025 | 2026-03-25 | 170.00 (+0.00%) |
Show
Entries
2seventy bio Inc Frequently Asked Questions
What is 2seventy bio Inc(MEX:TSVT)'s stock price today?
The current price of MEX:TSVT is MXN170.00. The 52 week high of MEX:TSVT is MXN170.00 and 52 week low is MXN170.00.
When is next earnings date of 2seventy bio Inc(MEX:TSVT)?
The next earnings date of 2seventy bio Inc(MEX:TSVT) is 2026-08-31 Est..
Does 2seventy bio Inc(MEX:TSVT) pay dividends? If so, how much?
2seventy bio Inc(MEX:TSVT) does not pay dividend.
Press Release
Articles on 2seventy bio Inc
No articles.